NVOH
NVOH
Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged • ADR hedged
$27.54 ▲ 3.09% (+0.82)
Managing Company ADR hedged
Asset Under Management $4.26M
Inception Date Jan 2, 2025
Expense Ratio 0.19%
52w High $38.51
52w Low $19.00
Volume 3,507
Avg Volume 2,396
Asset Class Equity
About Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
Managing Company ADR hedged
Asset Under Management $4.26M
Inception Date Jan 2, 2025
Expense Ratio 0.19%
52w High $38.51
52w Low $19.00
Volume 3,507
Avg Volume 2,396
Asset Class Equity
About Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 NVO | Novo Nordisk A/S | 97.00% | 84.26K | $4.07M |
ASSET ALLOCATION BY REGION
Denmark Other
2.74%ASSET ALLOCATION BY REGION
Denmark Other
2.74%